Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis

This study evaluates residual fatigue and cognitive defects in patients after leucine-rich glioma-inactivated 1 antibody encephalitis.

Detalles Bibliográficos
Autores principales: Binks, Sophie N. M., Veldsman, Michele, Easton, Ava, Leite, M. Isabel, Okai, David, Husain, Masud, Irani, Sarosh R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008400/
https://www.ncbi.nlm.nih.gov/pubmed/33779685
http://dx.doi.org/10.1001/jamaneurol.2021.0477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008400/
https://www.ncbi.nlm.nih.gov/pubmed/33779685
http://dx.doi.org/10.1001/jamaneurol.2021.0477

Ejemplares similares